Descladinose roxithromycin

Metabolite details

Identifier

BNZRPTCUAOMSSH-LKPWEDHSSA-N

InChI Key

BNZRPTCUAOMSSH-LKPWEDHSSA-N

IUPAC name

(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-4,7,12,13-tetrahydroxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one

Preferred name

Descladinose roxithromycin

INN name

—

Synonym

—

ChEBI

CHEBI:172795

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Comparative Metabolomic Profiling of Compatible and Incompatible Interactions Between Potato and Phytophthora infestans
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• 2:00 AM_Membrane_vs_2:00 AM_Net
• G1_PBS_vs_G2_DSS
• Ziyun_No.1_0h_vs_Ziyun_No.1_96h
• Control_vs_CSD
• Male_19_days_vs_Male_1_day
• Male_19_days_vs_Male_1_day
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT